Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk.

PubWeight™: 1.00‹?› | Rank: Top 15%

🔗 View Article (PMC 4320806)

Published in Nat Commun on October 24, 2014

Authors

Sara Lindström1, Deborah J Thompson2, Andrew D Paterson3, Jingmei Li4, Gretchen L Gierach5, Christopher Scott6, Jennifer Stone7, Julie A Douglas8, Isabel dos-Santos-Silva9, Pablo Fernandez-Navarro10, Jajini Verghase11, Paula Smith2, Judith Brown2, Robert Luben12, Nicholas J Wareham13, Ruth J F Loos14, John A Heit15, V Shane Pankratz6, Aaron Norman6, Ellen L Goode6, Julie M Cunningham16, Mariza deAndrade6, Robert A Vierkant6, Kamila Czene4, Peter A Fasching17, Laura Baglietto18, Melissa C Southey19, Graham G Giles18, Kaanan P Shah8, Heang-Ping Chan20, Mark A Helvie20, Andrew H Beck21, Nicholas W Knoblauch21, Aditi Hazra22, David J Hunter22, Peter Kraft23, Marina Pollan10, Jonine D Figueroa5, Fergus J Couch24, John L Hopper25, Per Hall4, Douglas F Easton26, Norman F Boyd27, Celine M Vachon6, Rulla M Tamimi22

Author Affiliations

1: 1] Program in Genetic Epidemiology and Statistical Genetics, Harvard School Of Public Health, Boston, Massachusetts 02115, USA [2] Department of Epidemiology, Harvard School Of Public Health, Boston, Massachusetts 02115, USA.
2: 1] Centre for Genetic Epidemiology, University of Cambridge, Cambridge CB1 8RN, UK [2] Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK.
3: Program in Genetics and Genome Biology, The Hospital for Sick Children, Toronto, Ontario, Canada M5G 1X8.
4: Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm 17177, Sweden.
5: Hormonal and Reproductive Epidemiology Branch, National Cancer Institute, Bethesda, Maryland 20850, USA.
6: Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA.
7: Centre for Genetic Origins of Health and Disease, University of Western Australia, Perth, Western Australia 6009, Australia.
8: Department of Human Genetics, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.
9: Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London WC1E 7HT, UK.
10: 1] Cancer and Environmental Epidemiology Unit, National Center for Epidemiology, Carlos III Institute of Health, Madrid 28029, Spain [2] Consortium for Biomedical Research in Epidemiology and Public Health (CIBER en Epidemiología y Salud Pública-CIBERESP), Madrid 28029, Spain.
11: 1] Centre for Genetic Epidemiology, University of Cambridge, Cambridge CB1 8RN, UK [2] Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK [3] Plastic Surgery Unit, Royal Free Hospital, London NW3 2QG, UK.
12: Centre for Genetic Epidemiology, University of Cambridge, Cambridge CB1 8RN, UK.
13: Medical Research Council (MRC) Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge CB1 8RN, UK.
14: 1] Medical Research Council (MRC) Epidemiology Unit, Institute of Metabolic Science, University of Cambridge, Cambridge CB1 8RN, UK [2] The Icahn School of Medicine at Mount Sinai, The Charles Bronfman Institute for Personalized Medicine, The Mindich Child Health and Development Institute, New York, New York 10029, USA.
15: Division of Cardiovascular Disease, Department of Medicine, Mayo Clinic, Rochester, Minnesota 55905, USA.
16: Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA.
17: 1] Department of Gynecology and Obstetrics, Erlangen University Hospital, Friedrich Alexander University of Erlangen-Nuremberg, Comprehensive Cancer Center Erlangen-EMN, 910 54 Erlangen, Germany [2] Division Hematology/Oncology, Department of Medicine, University of California at Los Angeles, David Geffen School of Medicine, Los Angeles, California 90024, USA.
18: 1] Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Victoria 3004, Australia [2] Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria 3010, Australia.
19: Department of Pathology, University of Melbourne, Melbourne, Victoria 3010, Australia.
20: Department of Radiology, University of Michigan Medical School, Ann Arbor, Michigan 48109, USA.
21: Department of Pathology, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, Massachusetts 02115, USA.
22: 1] Program in Genetic Epidemiology and Statistical Genetics, Harvard School Of Public Health, Boston, Massachusetts 02115, USA [2] Department of Epidemiology, Harvard School Of Public Health, Boston, Massachusetts 02115, USA [3] Channing Division of Network Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
23: 1] Program in Genetic Epidemiology and Statistical Genetics, Harvard School Of Public Health, Boston, Massachusetts 02115, USA [2] Department of Epidemiology, Harvard School Of Public Health, Boston, Massachusetts 02115, USA [3] Department of Biostatistics, Harvard School Of Public Health, Boston, Massachusetts 02115, USA.
24: 1] Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota 55905, USA [2] Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota 55905, USA.
25: Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Victoria 3010, Australia.
26: 1] Centre for Genetic Epidemiology, University of Cambridge, Cambridge CB1 8RN, UK [2] Department of Public Health and Primary Care, University of Cambridge, Cambridge CB1 8RN, UK [3] Department of Oncology, University of Cambridge, Cambridge CB1 8RN, UK.
27: Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, Toronto, Ontario, Canada M5G 2M9.

Articles citing this

The role of the insulin-like growth factor-1 system in breast cancer. Mol Cancer (2015) 1.05

Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures. Cancer Res (2015) 0.92

Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. Nat Genet (2016) 0.92

Identification of two novel mammographic density loci at 6Q25.1. Breast Cancer Res (2015) 0.79

Mammographic density and breast cancer risk by family history in women of white and Asian ancestry. Cancer Causes Control (2015) 0.78

Biomarkers in Patients with Metastatic Breast Cancer and the PRAEGNANT Study Network. Geburtshilfe Frauenheilkd (2015) 0.78

Using Breast Cancer Risk Associated Polymorphisms to Identify Women for Breast Cancer Chemoprevention. PLoS One (2017) 0.77

Breast cancer risk prediction using a clinical risk model and polygenic risk score. Breast Cancer Res Treat (2016) 0.77

DNA Methylation Patterns Can Estimate Nonequivalent Outcomes of Breast Cancer with the Same Receptor Subtypes. PLoS One (2015) 0.77

Integrated molecular landscape of Parkinson's disease. NPJ Parkinsons Dis (2017) 0.76

A comprehensive survey of genetic variation in 20,691 subjects from four large cohorts. PLoS One (2017) 0.75

Improved methods for multi-trait fine mapping of pleiotropic risk loci. Bioinformatics (2016) 0.75

A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density. Breast Cancer Res (2015) 0.75

Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapies. Oncotarget (2016) 0.75

Polymorphisms in the estrogen receptor alpha gene (ESR1), daily cycling estrogen and mammographic density phenotypes. BMC Cancer (2016) 0.75

ESR1 and PGR polymorphisms are associated with estrogen and progesterone receptor expression in breast tumors. Physiol Genomics (2016) 0.75

Stromal characteristics may hold the key to mammographic density: the evidence to date. Oncotarget (2016) 0.75

Association between breast cancer genetic susceptibility variants and terminal duct lobular unit involution of the breast. Int J Cancer (2016) 0.75

Amphiregulin as a Novel Serum Marker of Puberty in Girls. J Pediatr Adolesc Gynecol (2017) 0.75

Articles cited by this

Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc (2009) 137.99

An integrated encyclopedia of DNA elements in the human genome. Nature (2012) 64.73

An integrated map of genetic variation from 1,092 human genomes. Nature (2012) 59.82

Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res (2008) 54.83

Comprehensive molecular portraits of human breast tumours. Nature (2012) 47.39

Multipoint quantitative-trait linkage analysis in general pedigrees. Am J Hum Genet (1998) 40.97

Genome-wide association study identifies novel breast cancer susceptibility loci. Nature (2007) 29.23

METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics (2010) 21.21

Annotation of functional variation in personal genomes using RegulomeDB. Genome Res (2012) 11.47

HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res (2011) 11.03

Robust variance-components approach for assessing genetic linkage in pedigrees. Am J Hum Genet (1994) 10.58

Genome-wide association study identifies a new breast cancer susceptibility locus at 6q25.1. Nat Genet (2009) 8.44

Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24

Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet (2010) 7.62

ProbABEL package for genome-wide association analysis of imputed data. BMC Bioinformatics (2010) 6.46

Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med (2002) 6.19

The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS Genet (2011) 5.95

Pooled analysis of prospective cohort studies on height, weight, and breast cancer risk. Am J Epidemiol (2000) 4.83

Genevar: a database and Java application for the analysis and visualization of SNP-gene associations in eQTL studies. Bioinformatics (2010) 4.56

Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81

Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol (2010) 3.75

Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet (2012) 3.20

Mammographic density, breast cancer risk and risk prediction. Breast Cancer Res (2007) 2.71

A candidate gene approach to searching for low-penetrance breast and prostate cancer genes. Nat Rev Cancer (2005) 2.62

A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet (2012) 2.45

Mammographic density phenotypes and risk of breast cancer: a meta-analysis. J Natl Cancer Inst (2014) 2.10

Symmetry of projection in the quantitative analysis of mammographic images. Eur J Cancer Prev (1996) 2.00

Genome-wide association study in east Asians identifies novel susceptibility loci for breast cancer. PLoS Genet (2012) 1.91

Common variants in ZNF365 are associated with both mammographic density and breast cancer risk. Nat Genet (2011) 1.77

Ancestry-shift refinement mapping of the C6orf97-ESR1 breast cancer susceptibility locus. PLoS Genet (2010) 1.74

Body fatness at young ages and risk of breast cancer throughout life. Am J Epidemiol (2010) 1.56

Genome-wide association study identifies breast cancer risk variant at 10q21.2: results from the Asia Breast Cancer Consortium. Hum Mol Genet (2011) 1.55

Association between cutaneous nevi and breast cancer in the Nurses' Health Study: a prospective cohort study. PLoS Med (2014) 1.48

Nondense mammographic area and risk of breast cancer. Breast Cancer Res (2011) 1.45

The heritability of mammographically dense and nondense breast tissue. Cancer Epidemiol Biomarkers Prev (2006) 1.35

Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer. Carcinogenesis (2013) 1.28

Genetic variants associated with breast size also influence breast cancer risk. BMC Med Genet (2012) 1.26

Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk. Cancer Epidemiol Biomarkers Prev (2012) 1.26

Genome-wide association study identifies nidogen 1 (NID1) as a susceptibility locus to cutaneous nevi and melanoma risk. Hum Mol Genet (2011) 1.10

Mammographic breast density and breast cancer: evidence of a shared genetic basis. Cancer Res (2012) 1.03

Identification of a novel percent mammographic density locus at 12q24. Hum Mol Genet (2012) 0.88

Association between melanocytic nevi and risk of breast diseases: The French E3N prospective cohort. PLoS Med (2014) 0.82

Activation of the MKL1/actin signaling pathway induces hormonal escape in estrogen-responsive breast cancer cell lines. Mol Cell Endocrinol (2014) 0.78

Articles by these authors

Genetic studies of body mass index yield new insights for obesity biology. Nature (2015) 8.27

Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche. Nature (2014) 1.88

Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Nat Commun (2014) 1.19

Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk. Hum Mol Genet (2014) 1.05

Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression. Am J Hum Genet (2015) 1.00

PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. J Med Genet (2016) 0.95

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer. Nat Commun (2016) 0.89

Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. Hum Mol Genet (2015) 0.88

Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. Nat Commun (2016) 0.82

Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. Nat Commun (2015) 0.82

Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia. Nat Commun (2016) 0.81

An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. Hum Mol Genet (2016) 0.75